rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-3-31
|
pubmed:abstractText |
The aim of the present trial was to evaluate the efficacy of a combined product in the treatment of common cold and to examine the contribution of the separate components. In the published literature there is conflicting data on the efficacy of agents used in the treatment of common cold, especially when given in drug combinations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0946-1965
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
114-25
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12665160-Acetaminophen,
pubmed-meshheading:12665160-Adolescent,
pubmed-meshheading:12665160-Adult,
pubmed-meshheading:12665160-Aged,
pubmed-meshheading:12665160-Analgesics, Non-Narcotic,
pubmed-meshheading:12665160-Ascorbic Acid,
pubmed-meshheading:12665160-Caffeine,
pubmed-meshheading:12665160-Chlorpheniramine,
pubmed-meshheading:12665160-Common Cold,
pubmed-meshheading:12665160-Double-Blind Method,
pubmed-meshheading:12665160-Drug Combinations,
pubmed-meshheading:12665160-Histamine H1 Antagonists,
pubmed-meshheading:12665160-Humans,
pubmed-meshheading:12665160-Middle Aged,
pubmed-meshheading:12665160-Phosphodiesterase Inhibitors,
pubmed-meshheading:12665160-Prospective Studies,
pubmed-meshheading:12665160-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Evaluation of the efficacy of a combined formulation (Grippostad-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial.
|
pubmed:affiliation |
CCDRD AG, Neuenhagen, Germany. rkoytchev@drug-news.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|